Ongoing Clinical Trials

Clinical Trials Currently Recruiting Patients:

Dermatology Research Registry 

If you are interested in possibly participating in any of our current or future research studies, please sign up for our Dermatology Research Registry online at:    https://studypages.com/uncderm

 

Your information will be kept confidential and will only be used to contact you about potential research studies.  Your information will not be shared.

Adult Atopic Dermatitis Research Study (Injectable Medication)

Requirements:Adults (18 years and older) with moderate to severe atopic dermatitis. Must be in general good health and have not had adequate response to topical medications.

Duration: One screening visit, one baseline visit, and monthly clinic visits at UNC Dermatology over the course of 32 weeks.

Incentive: Reimbursement for travel. Investigational study medication, study-related exams, and lab tests will be provided at no cost.


Sponsor: Supported by Galderma Pharmaceuticals

For more information please contact:    Taylor Zuber
                                                                     984-974-3682
                                                                     taylor_zuber@med.unc.edu


 

Pediatric Psoriasis Research Study (Injectable Medication)
Requirements: Children (6-17 years) with moderate to severe plaque type psoriasis. Children should be in general good health, with no history of Etanercept use.

Duration:   One screening visit, one baseline visit, and monthly clinic visits at UNC Dermatology over the course of 33 months.

 

Incentive: Subject compensation available.  Investigational study medication, study-related exams, and lab tests will be provided at no cost. 

 

Sponsor: Supported by Eli Lilly and Company

 

For more information please contact:    Taylor Zuber
                                                                    984-974-3682
                                                                    taylor_zuber@med.unc.edu

 

Pemphigus (Vulgaris or Foliaceus) Research Study (Infusion Medication)
Requirements: Patients (18+) with diagnosis of pemphigus (vulgaris or foliaceus) who have active disease.  Other requirements will be discussed with study staff.

 

Duration: Up to 18 total visits over the course of 18 weeks.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost. 

 

 Sponsor: Supported by Syntimmune, Inc.

 

For more information please contact:    Laura Keck
                                                                    984-974-3682
                                                                 
   lmcleod@email.unc.edu


 

Epidermolysis Bullosa Simplex (EBS) Research Study (Topical) Medication


Requirements: Patients (4+) with epidermolysis bullosa simplex. Additional treatments
other than the study medication are not permitted during the study period.

Duration: 8 total visits, 3 day to 6 week screening period, 8 week treatment period, plus a follow-up visit 4 weeks and 8 weeks after completing therapy.

Incentive: Subject compensation and travel assistance available. Study medication, study related exams, and lab tests will be provided at no cost.

Sponsor: Supported by Castle Creek Pharmaceuticals LLC


For more information please contact:

Laura Keck
984-974-3682
laura_mcleod@med.unc.edu


 

 

 

Your Physician:
Aida Lugo-Somolinos, MD
Link to Dr. Lugo-Somolinos' Research